Alessa Therapeutics Inc. Company
Alessa Therapeutics is focused on development, clinical validation, and commercialization of localized, sustained drug delivery for early interception of cancer and other solid organ disease.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership